Harms reporting limited in trials of prebiotics, probiotics, synbiotics

phys.org | 7/17/2018 | Staff
red815 (Posted by) Level 3
Click For Photo: https://3c1703fe8d.site.internapcdn.net/newman/gfx/news/2018/harmsreporti.jpg

(HealthDay)—A considerable number of randomized controlled trials (RCTs) of probiotics, prebiotics, or synbiotics do not report harms-related data and/or safety results, according to a review published online July 17 in the Annals of Internal Medicine.

Aïda Bafeta, Ph.D., from the Université Paris Descartes-Sorbonne Paris Cité, and colleagues examined how harms-related information is reported in publications of RCTs of probiotics, prebiotics, and synbiotics. RCTs included in the review assessed the safety or efficacy of at least one intervention versus any control for any clinical condition.

Researchers - Percent - Trials - Volunteers - Trials

The researchers found that 88 percent of the 384 trials conducted in healthy volunteers (136 trials) or patients with any of several medical conditions (248 trials) were published in specialty journals. Probiotics were most often evaluated (69 percent). Outpatients and high-risk patients were enrolled in studies of persons with medical conditions...
(Excerpt) Read more at: phys.org
Wake Up To Breaking News!
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!